The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis

Abstract

Background Due to the inconsistent use of diagnostic criteria in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), it is unsure whether physiotherapeutic management regarded effective in ME/CFS is appropriate for patients diagnosed with criteria that consider post-exertional malaise (PEM) as a hallmark feature. Purpose To appraise current evidence of the effects of physiotherapy on symptoms and functioning in ME/CFS patients in view of the significance of PEM in the applied diagnostic criteria for inclusion. Methods A systematic review of randomized controlled trials published over the last two decades was conducted. Studies evaluating physiotherapeutic interventions for adult ME/CFS patients were included. The diagnostic criteria sets were classified into three groups according to the extent to which the importance of PEM was emphasized: chronic fatigue (CF; PEM not mentioned as a criterion), CFS (PEM included as an optional or minor criterion) or ME (PEM is a required symptom). The main results of included studies were synthesized in relation to the classification of the applied diagnostic criteria. In addition, special attention was given to the tolerability of the interventions. Results Eighteen RCTs were included in the systematic review: three RCTs with CF patients, 14 RCTs with CFS patients and one RCT covering ME patients with PEM. Intervention effects, if any, seemed to disappear with more narrow case definitions, increasing objectivity of the outcome measures and longer follow-up. Conclusion Currently, there is no scientific evidence when it comes to effective physiotherapy for ME patients. Applying treatment that seems effective for CF or CFS patients may have adverse consequences for ME patients and should be avoided.

COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents

“…In a different case–control study in the same country, 138 mildly affected patients were matched with 82 negative controls, and serum 25(OH)D levels were significantly lower in affected people but were not a predictor of disease outcome. That finding called for additional large population-based RCTs to further confirm the results [ 73 ].…”

Extremely Severe ME/CFS—A Personal Account

“…From that moment on, I didn’t have anyone in my room without earphones and earmuffs. Only when I discovered Ativan and Abilify [ 7 ] in the last few months of 2020 and improved was I able to be around people without earmuffs and actually listen to them speak, but only with Ativan or when my body naturally releases adrenaline to enable me to get up to have a bowel movement in the bathroom (a 6-foot walk). I will explain this natural adrenaline release later in this article.…”

Diagnosis and prediction of COVID-19 severity: can biochemical tests and machine learning be used as prognostic indicators?

“…Previous machine learning studies highlight that some demographic variables, patients’ comorbidities, and laboratory findings can be predictive factors for COVID-19 mortality [ [9] , [10] , [11] , [12] ]. However, most of these studies included a small sample size, which may impact the model’s robustness and reliability of findings (e.g., low sensitivity) [ [14] , [15] , [16] ] and prevent its use in practice. Moreover, to date, specific biomarkers associated with the disease severity and patients’ hospitalisation in intensive care units are still unknown, which may hamper the development of further targeted treatments [ 13 ].…”